1456693-00-7

Basic information

• Product Name: (R)-benzyl (1-((2,2-dimethoxyethyl)amino)-3-methyl-1-oxobutan-2-yl)carbamate
• Synonyms: (R)-benzyl (1-((2,2-dimethoxyethyl)amino)-3-methyl-1-oxobutan-2-yl)carbamate
• CAS NO: 1456693-00-7
• Molecular Formula: C₁₇H₂₆N₂O₅
• Molecular Weight: 338.39874
• Mol File: 1456693-00-7.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (R)-benzyl (1-((2,2-dimethoxyethyl)amino)-3-methyl-1-oxobutan-2-yl)carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-benzyl (1-((2,2-dimethoxyethyl)amino)-3-methyl-1-oxobutan-2-yl)carbamate(1456693-00-7)
• EPA Substance Registry System: (R)-benzyl (1-((2,2-dimethoxyethyl)amino)-3-methyl-1-oxobutan-2-yl)carbamate(1456693-00-7)

Safety Data

• Hazardous Substances Data: 1456693-00-7(Hazardous Substances Data)

Usage

General Description

(R)-benzyl (1-((2,2-dimethoxyethyl)amino)-3-methyl-1-oxobutan-2-yl)carbamate is a chemical compound with the chemical formula C18H27NO6. (R)-benzyl (1-((2,2-dimethoxyethyl)amino)-3-methyl-1-oxobutan-2-yl)carbamate is a carbamate derivative and has a complex and unique structure. It contains a benzyl group and an amino group, as well as a carbamate functional group. The compound also includes a methyl group and a 2,2-dimethoxyethyl group. (R)-benzyl (1-((2,2-dimethoxyethyl)amino)-3-methyl-1-oxobutan-2-yl)carbamate may have potential applications in pharmaceuticals, agriculture, or materials science due to its complex and potentially versatile structure. Further research and testing would be necessary to determine its specific uses and properties.

Upstream product

• 1685-33-2 N-[(benzyloxy)carbonyl]-D-valine 
• 22483-09-6 2,2-dimethoxyethylamine 

Downstream Products

• 1456693-01-8 (R)-benzyl 2-isopropyl-3-oxo-3,4-dihydropyrazine-1(2H)-carboxylate 
• 1456693-02-9 (R)-benzyl 2-isopropyl-3-oxopiperazine-1-carboxylate 
• 1240590-09-3 (R)-3-isopropyl-piperazin-2-one 
• 1456693-04-1 (R)-tert-butyl 4-(5-fluoro-4-(methoxycarbonyl)-2-nitrophenyl)-2-isopropyl-3-oxopiperazine-1-carboxylate 
• 1456693-05-2 (R)-tert-butyl 2-isopropyl-4-(4-(methoxycarbonyl)-5-(methylthio)-2-nitrophenyl)-3-oxopiperazine-1-carboxylate 
• 1456693-06-3 (R)-tert-butyl 2-isopropyl-4-(4-(methoxycarbonyl)-5-(methylsulfonyl)-2-nitrophenyl)-3-oxopiperazine-1-carboxylate 
• 1456693-07-4 (R)-tert-butyl 4-(2-amino-4-(methoxycarbonyl)-5-(methylsulfonyl)phenyl)-2-isopropyl-3-oxopiperazine-1-carboxylate 
• 1456693-55-2 (R)-methyl 1-isopropyl-7-(methylsulfonyl)-1,2,3,4-tetrahydrobenzo[4,5]imidazo [1,2-a]pyrazine-8-carboxylate 
• 1456704-59-8 (R)-methyl 1-isopropyl-7-(methylsulfonyl)-2-(4-(trifluoromethyl)pyrimidin-2-yl)-1,2,3,4-tetrahydrobenzo[4,5]imidazo[1,2-a]pyrazine-8-carboxylate 

Relevant articles and documents

COMPOUNDS FOR USE IN TREATING ACUTE CORONARY SYNDROME AND RELATED CONDITIONS

Provided herein are compounds and pharmaceutically acceptable salts thereof that are useful therapeutics for acute coronary syndrome and related disorders.

LIVER X RECEPTION MODULATORS

Provided herein are novel compounds and pharmaceutically acceptable salts thereof that are liver X receptor modulators. Also provided are compositions comprising compounds of the invention and a carrier. Additionally, use of the compounds herein and methods for treating a disease or disorder associated with the liver X receptor are further described.